Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Lakefront Biotherapeutics NV (LKFT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. LKFT is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 2 institutional filers currently hold this stock. LKFT trades on the Nasdaq exchange and files with the SEC under CIK 1421876. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LKFT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lakefront Biotherapeutics NV directly from SEC EDGAR.
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 20-F | $1.1B | — | — |
| FY 2024 | 20-F | $275.6M | — | — |
| FY 2023 | 20-F | $239.7M | — | — |
| FY 2022 | 20-F | $241.2M | — | — |
| FY 2021 | 20-F | $234.4M | — | — |
| FY 2020 | 20-F | $478.1M | — | — |
13F Pro Quality Score
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 2 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Financial metrics will appear once SEC EDGAR data is ingested for this company.